MacDonald J, Bradshaw G, Jochems F, Bernards R, Letai A
Cell Death Differ. 2025; .
PMID: 39762561
DOI: 10.1038/s41418-024-01431-1.
Zhu Q, Zhu Z, Renaud S, Hu L, Guo Y
J Mol Neurosci. 2023; 73(6):327-344.
PMID: 37223854
DOI: 10.1007/s12031-023-02120-3.
Sadler K, Bowes J, Rowlands C, Perez-Becerril C, van der Meer C, King A
Brain. 2022; 146(7):2861-2868.
PMID: 36546557
PMC: 10317144.
DOI: 10.1093/brain/awac478.
Gong Y, Liu Z, Yuan Y, Yang Z, Zhang J, Lu Q
Nat Commun. 2022; 13(1):1627.
PMID: 35338151
PMC: 8956581.
DOI: 10.1038/s41467-022-29309-1.
Lefevre L, Iacovoni J, Martini H, Belliere J, Maggiorani D, Dutaur M
Cell Mol Life Sci. 2020; 78(7):3485-3501.
PMID: 33313981
PMC: 8038964.
DOI: 10.1007/s00018-020-03719-0.
Gankyrin Oncoprotein: Structure, Function, and Involvement in Cancer.
Li J, Guo Y
Curr Chem Biol. 2020; 4(1):13-19.
PMID: 32775187
PMC: 7410172.
DOI: 10.2174/2212796811004010013.
Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation.
Xia Q, Zhang H, Zhang P, Li Y, Xu M, Li X
Oncogene. 2020; 39(36):5902-5915.
PMID: 32737433
DOI: 10.1038/s41388-020-01400-1.
MCL1 binding to the reverse BH3 motif of P18INK4C couples cell survival to cell proliferation.
Whitaker R, Placzek W
Cell Death Dis. 2020; 11(2):156.
PMID: 32111816
PMC: 7048787.
DOI: 10.1038/s41419-020-2351-1.
Heterogeneous , , , and Gene Expression Profiles in Primary GBM: No Association with Patient Survival.
Gonzalez-Tablas M, Arandia D, Jara-Acevedo M, Otero A, Vital A, Prieto C
Cancers (Basel). 2020; 12(1).
PMID: 31963499
PMC: 7016708.
DOI: 10.3390/cancers12010231.
The Genetic Landscape of Human Glioblastoma and Matched Primary Cancer Stem Cells Reveals Intratumour Similarity and Intertumour Heterogeneity.
Pesenti C, Navone S, Guarnaccia L, Terrasi A, Costanza J, Silipigni R
Stem Cells Int. 2019; 2019:2617030.
PMID: 30984267
PMC: 6431486.
DOI: 10.1155/2019/2617030.
A new method of identifying glioblastoma subtypes and creation of corresponding animal models.
Zhou X, Li G, An S, Li W, Yang H, Guo Y
Oncogene. 2018; 37(35):4781-4791.
PMID: 29769617
DOI: 10.1038/s41388-018-0305-1.
Identification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancer.
Zhang L, Yuan Y, Lu K, Zhang L
BMC Bioinformatics. 2016; 17(1):222.
PMID: 27230211
PMC: 4881176.
DOI: 10.1186/s12859-016-1085-7.
MicroRNA-130b promotes cell proliferation and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma cells.
Gu J, Zhang J, Chen H, Wang S
Int J Mol Med. 2016; 37(6):1587-93.
PMID: 27122306
PMC: 4866956.
DOI: 10.3892/ijmm.2016.2580.
Forging a signature of in vivo senescence.
Sharpless N, Sherr C
Nat Rev Cancer. 2015; 15(7):397-408.
PMID: 26105537
DOI: 10.1038/nrc3960.
BioMiner: Paving the Way for Personalized Medicine.
Bauer C, Stec K, Glintschert A, Gruden K, Schichor C, Or-Guil M
Cancer Inform. 2015; 14:55-63.
PMID: 26005322
PMC: 4406277.
DOI: 10.4137/CIN.S20910.
MicroRNA-27a distinguishes glioblastoma multiforme from diffuse and anaplastic astrocytomas and has prognostic value.
Rivera-Diaz M, Miranda-Roman M, Soto D, Quintero-Aguilo M, Ortiz-Zuazaga H, Marcos-Martinez M
Am J Cancer Res. 2015; 5(1):201-18.
PMID: 25628931
PMC: 4300691.
Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide.
Cuperlovic-Culf M, Touaibia M, St-Coeur P, Poitras J, Morin P, Culf A
Metabolites. 2014; 4(3):807-30.
PMID: 25222834
PMC: 4192694.
DOI: 10.3390/metabo4030807.
Epigenetic setting and reprogramming for neural cell fate determination and differentiation.
Imamura T, Uesaka M, Nakashima K
Philos Trans R Soc Lond B Biol Sci. 2014; 369(1652).
PMID: 25135972
PMC: 4142032.
DOI: 10.1098/rstb.2013.0511.
Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis.
Jarry M, Lecointre C, Malleval C, Desrues L, Schouft M, Lejoncour V
Neuro Oncol. 2014; 16(11):1484-98.
PMID: 24891448
PMC: 4201071.
DOI: 10.1093/neuonc/nou102.
NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development.
Piper M, Barry G, Harvey T, McLeay R, Smith A, Harris L
J Neurosci. 2014; 34(8):2921-30.
PMID: 24553933
PMC: 3931505.
DOI: 10.1523/JNEUROSCI.2319-13.2014.